SCHEMBL1084013

SCHEMBL1084013

CCOC(=O)C1CCN(c2nc(-c3ccccc3O)nc3cc(Cl)ccc23)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.57
KDM4E B2RXH2 5/20 0.57
TP53 P04637 2/20 0.57
ALDH1A1 P00352 5/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
HTT P42858 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
TSHR P16473 3/20 0.49
HSD17B10 Q99714 2/20 0.49
ALOX12 P18054 1/20 0.49
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
SMAD3 P84022 1/20 0.47
CHEK2 O96017 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
NPSR1 Q6W5P4 3/20 0.46
HPGD P15428 2/20 0.46
POLB P06746 1/20 0.46
RAB9A P51151 2/20 0.45
ATM Q13315 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084815 0.95 MAPT (0.53) MAPTKDM4ETP53ALDH1A1SMN1; SMN2
SCHEMBL1084376 0.90 MAPT (0.56) MAPTKDM4ETP53ALDH1A1SMN1; SMN2
SCHEMBL1083969 0.89 MAPT (0.71) MAPTKDM4ETP53ALDH1A1SMN1; SMN2
SCHEMBL1084566 0.86 MAPT (0.54) MAPTKDM4ETP53ALDH1A1SMN1; SMN2
SCHEMBL1084603 0.86 CHEK2 (0.48) MAPTKDM4ETP53ALDH1A1TSHR
SCHEMBL1084381 0.84 SMAD3 (0.54) MAPTALDH1A1TDP1TSHRHSD17B10
SCHEMBL13342837 0.84 MAPT (0.53) MAPTKDM4ETP53ALDH1A1TSHR
SCHEMBL1084360 0.83 SMAD3 (0.54) MAPTALDH1A1TSHRMEN1KMT2A
SCHEMBL1084511 0.82 SMAD3 (0.53) MAPTKDM4EALDH1A1TDP1TSHR
SCHEMBL1084374 0.82 SMAD3 (0.53) MAPTALDH1A1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed